BTI
TEVA icon

Blue Trust Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Blue Trust Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.7K Buy
2,086
+1,408
+208% +$46.9K ﹤0.01% 1190
2026
Q1 		$20.4K Sell
678
-57
-8% -$1.83K ﹤0.01% 1640
2025
Q4 		$22.9K Sell
735
-20
-3% -$493 ﹤0.01% 1640
2025
Q3 		$15.3K Hold
755
– – ﹤0.01% 1744
2025
Q2 		$12.7K Sell
755
-13
-2% -$210 ﹤0.01% 1820
2025
Q1 		$11.8K Sell
768
-4,899
-86% -$87.5K ﹤0.01% 1824
2024
Q4 		$125K Sell
5,667
-8,952
-61% -$163K ﹤0.01% 846
2024
Q3 		$238K Buy
14,619
+4,185
+40% +$73.2K ﹤0.01% 782
2024
Q2 		$147K Buy
10,434
+6,481
+164% +$99.8K ﹤0.01% 819
2024
Q1 		$55.8K Sell
3,953
-588
-13% -$7.41K ﹤0.01% 877
2023
Q4 		$46K Buy
4,541
+2,180
+92% +$20.4K ﹤0.01% 971
2023
Q3 		$18K Sell
2,361
-421
-15% -$3.92K ﹤0.01% 1217
2023
Q2 		$25K Buy
2,782
+520
+23% +$4.22K ﹤0.01% 969
2023
Q1 		$21K Sell
2,262
-1,415
-38% -$14K ﹤0.01% 1348
2022
Q4 		$30K Buy
3,677
+3,401
+1,232% +$29.7K ﹤0.01% 1135
2022
Q3 		$2K Buy
276
+240
+667% +$2.12K ﹤0.01% 1835
2022
Q2 		$0 Buy
+36
New +$314 ﹤0.01% 2006

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Blue Trust Inc's TEVA Position: Q2 2026 in Review

Blue Trust Inc increased its Teva Pharmaceuticals (TEVA) stake by 208% in Q2 2026, buying an estimated $46.9K and bringing the position to 2,086 shares worth $70.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Blue Trust Inc first reported a position in TEVA in Q2 2022 and has held it in 17 quarters since. The position peaked at $238K in Q3 2024. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Blue Trust Inc held 2,086 shares of Teva Pharmaceuticals worth $70.7K as of Q2 2026.
  • Blue Trust Inc bought 1,408 Teva Pharmaceuticals shares in Q2 2026, an estimated $46.9K.
  • Teva Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1190 holding.
  • Blue Trust Inc first reported a position in Teva Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Teva Pharmaceuticals position peaked at $238K in Q3 2024.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.